<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR886.html">Part 886
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 886.5700  Eyelid weight.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identification. An eyelid weight is a prescription device made  of gold, tantalum, platinum, iridium, or surgical grade stainless steel  that is rectangular in shape and contoured to the shape of the eye. The  device is intended for the gravity assisted treatment of lagophthalmos  (incomplete eyelid closure).</p><p class="depth2"><em>(1)</em> The external eyelid weight is adhered to the outer skin of the  upper eyelid.</p><p class="depth2"><em>(2)</em> The implantable eyelid weight is implanted into the upper  eyelid.</p><p class="depth1"><em>(b)</em> Classification. </p><p class="depth2"><em>(1)</em> Class II (special controls) for the external  eyelid weight. The external eyelid weight is exempt from the premarket  notification procedures in subpart E of part 807 of this chapter subject  to the limitations in Sec. 886.9. The special controls for the external  eyelid weight are:</p><p class="depth3"><em>(i)</em> Testing demonstrating the biocompatibility of the device; and</p><p class="depth3"><em>(ii)</em> Labeling must include the following information:</p><p class="depth4"><em>(A)</em> Specific instructions regarding the proper placement, sizing,  and removal of the device; and</p><p class="depth4"><em>(B)</em> A warning stating that the patient should be instructed to  remove the device prior to entering a magnetic resonance environment.</p><p class="depth2"><em>(2)</em> Class II (special controls) for the implantable eyelid weight.  The special controls for the implantable eyelid weight are:</p><p class="depth3"><em>(i)</em> Testing demonstrating the biocompatibility of the device;</p><p class="depth3"><em>(ii)</em> Testing demonstrating the sterility and shelf life of the  device;</p><p class="depth3"><em>(iii)</em> Nonclinical testing evaluating the compatibility of the device  in a magnetic resonance environment.</p><p class="depth3"><em>(iv)</em> Patient labeling to convey information regarding the safety and  compatibility of the device in a magnetic resonance environment, the  conditions under which a patient with the device can be safely scanned,  and a mechanism for a healthcare provider to obtain detailed information  about magnetic resonance safety and compatibility if needed.  [79 FR 22015, Apr. 21, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
